Bleeding risk with concomitant use of tiro ban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction


TİGEN M. K. , ÖZDİL M. H. , ÇİNÇİN A. A. , KANAR B., GÜREL E., SÜNBÜL M. , ...Daha Fazla

33nd Turkish Cardiology Congress With International Participation, 5 - 08 Ekim 2017